Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment …
$1.72+0.58%
报价 2026-11-06
市值
$122.4M
EV
$210.8M
PE (TTM)
–
预期 PE (FY2026)
–
52 周区间距高点 -74.0%
$1.30$6.61
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
excluded industry: Biotechnology
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| ZNTLZentalis Pharmaceuticals, Inc. | $122.4M | +0.6% | -22.2% | 0% | – | – | – | |
| IMMXImmix Biopharma, Inc. | $668.2M | +11.9% | +72.9% | 0% | – | – | – | |
| STTKShattuck Labs, Inc. | $463.7M | +2.9% | +33.3% | -82% | – | – | – | |
| DTILPrecision BioSciences, Inc. | $292.6M | +7.4% | +125.3% | 98.7% | – | – | – | |
| ARTVArtiva Biotherapeutics, Inc. | $202.9M | +0.5% | -100.0% | 0% | – | – | – | |
| WHWKWhitehawk Therapeutics Inc | $178.4M | +3.6% | +23.9% | 0% | – | – | – | |
| ALXOALX Oncology Holdings Inc. | $159.7M | +0.4% | +666.7% | 0% | – | – | – | |
| STROSutro Biopharma, Inc. | $159.5M | +4.6% | -66.8% | 98.7% | – | – | – | |
| MGNXMacroGenics, Inc. | $148.4M | +5.0% | -21.0% | 50.4% | – | – | – | |
| 同行中位数 | – | – | +28.6% | 0% | – | – | – |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。